Global Antibiotics Market Report 2024

Antibiotics Global Market Report 2025 – By Drug Class (Penicillin, Cephalosporin, Aminoglycosides, Tetracycline, Macrolides, Fluoroquinolones, Sulfonamides, Other Classes), By Spectrum Of Activity (Broad-spectrum Antibiotic, Narrow-spectrum Antibiotic), By Route Of Administration (Oral, Intravenous, Other Routes), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By Application (Skin Infections, Respiratory Infections, Urinary Tract Infections, Septicemia, Ear Infections, Gastrointestinal Infections, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

Antibiotics Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Antibiotics Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN

Antibiotics Market Definition

Antibiotics are a class of medications that work by either killing bacteria or inhibiting their growth, helping the body's immune system eliminate the infection. Antibiotics are used in the treatment of various infections caused by bacteria.

The main drug classes of antibiotics are penicillin, cephalosporin, aminoglycosides, tetracycline, macrolides, fluoroquinolones, sulfonamides, and others. Penicillin is a group of antibiotics derived from the fungus Penicillium. The various spectrums of activity include broad-spectrum antibiotics and narrow-spectrum antibiotics. The various routes of administration include oral, intravenous, and other routes, and they are sold through several distribution channels, such as hospital pharmacies, retail pharmacies, and online pharmacies, and various applications, including skin infections, respiratory infections, urinary tract infections, septicemia, ear infections, gastrointestinal infections, and others.

Antibiotics Market Segmentation

The antibiotics market covered in this report is segmented –

1) By Drug Class: Penicillin, Cephalosporin, Aminoglycosides, Tetracycline, Macrolides, Fluoroquinolones, Sulfonamides, Other Classes

2) By Spectrum Of Activity: Broad-spectrum Antibiotic, Narrow-spectrum Antibiotic

3) By Route Of Administration: Oral, Intravenous, Other Routes

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

5) By Application: Skin Infections, Respiratory Infections, Urinary Tract Infections, Septicemia, Ear Infections, Gastrointestinal Infections, Other Applications

Subsegments:

1) By Penicillin: Natural Penicillins, Aminopenicillins, Penicillinase-resistant Penicillins, Extended-spectrum Penicillins

2) By Cephalosporin: First-generation, Second-generation, Third-generation, Fourth-generation, Fifth-generation

3) By Aminoglycosides: Gentamicin, Tobramycin, Amikacin, Neomycin

4) By Tetracycline: Tetracycline, Doxycycline, Minocycline, Oxytetracycline

5) By Macrolides: Erythromycin, Azithromycin, Clarithromycin

6) By Fluoroquinolones: Ciprofloxacin, Levofloxacin, Moxifloxacin, Ofloxacin

7) By Sulfonamides: Sulfamethoxazole, Sulfadiazine, Sulfasalazine

8) By Other Classes: Glycopeptides, Lipopeptides, Streptogramins, Polymyxins

Antibiotics Market Size and growth rate 2025 to 2029: Graph

Antibiotics Market Size 2025 And Growth Rate

The antibiotics market size has grown strongly in recent years. It will grow from $84.68 billion in 2024 to $89.31 billion in 2025 at a compound annual growth rate (CAGR) of 5.5%. The growth in the historic period can be attributed to increased incidence of infectious diseases, growing population and urbanization, rising healthcare awareness, access to healthcare services, prevalence of antibiotic-resistant strains

Antibiotics Market Growth Forecast

The antibiotics market size is expected to see strong growth in the next few years. It will grow to $110.65 billion in 2029 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to global health threats, rising healthcare expenditure, government initiatives and regulations, increased international collaboration. Major trends in the forecast period include development of oral antibiotics, collaboration and partnerships for antibiotic development, regulatory incentives and pathways, antimicrobial stewardship programs in healthcare, global health initiatives for antibiotic access.

Antibiotics Market Driver: Surge In Bacterial Prevalence Drives Growth In The Antibiotics Market

The rising prevalence of bacterial infections is expected to drive the antibiotics market going forward. Bacterial infections refer to infections caused by bacteria, which are microscopic single-celled organisms. Antibiotics are extremely helpful in the treatment and prevention of bacterial diseases because they prevent the growth of bacteria. For instance, in February 2023, according to the World Health Organization, a Switzerland-based specialized health agency of the United States, 30 countries in the world were suffering from a cholera epidemic in 2022. The case fatality ratio (CFR) of cholera was 1.9% in 2021, which was the highest recorded in a decade. As a result, the rising prevalence of bacterial infections is driving the antibiotics market.

Antibiotics Market Driver: Antibiotic Market Growth Fueled By Growing Population Needs

The increased healthcare needs of a growing population are expected to propel the growth of the antibiotics market going forward. Healthcare needs for a growing population refer to the increasing demand and requirements for medical services, resources, and infrastructure to address the healthcare challenges arising from a larger and expanding population. The increasing population necessitates the use of antibiotics to treat bacterial infections, prevent infectious diseases, and protect public health. Antibiotics are used in treating a variety of illnesses, reducing morbidity and mortality, managing infectious diseases effectively, and supporting medical interventions like surgeries, chemotherapy, and immunosuppressive therapies. Proper antibiotic use is essential to meet the healthcare needs of a growing population and maintain global health standards. For instance, in September 2022, according to the U.S. Census Bureau, a US-based government organization, the United States' resident population increased by 0.4%, or 1,256,003, to 333,287,557 in 2022. Therefore, the increased healthcare needs of a growing population are driving the antibiotics market.

Global Antibiotics Market Major Players

Major companies operating in the antibiotics market include Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi SA, Bristol Myers Squibb (BMS), AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc (GSK), Eli Lilly and Company, Gilead Sciences Inc., Boehringer Ingelheim, Viatris Inc, Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Daiichi Sankyo Company, Sun Pharmaceutical Industries Limited, Cipla Ltd., Ferring Pharmaceuticals, Hikma Pharmaceuticals plc, Lupin Pharmaceuticals Inc., Torrent Pharmaceuticals Ltd., Glenmark Pharmaceuticals Limited, Basilea Pharmaceutica Ltd., Paratek Pharmaceuticals Inc., Spero Therapeutics Inc., Nabriva Therapeutics Plc

Global Antibiotics Market Trend: Breaking Ground Against Antibiotic Resistance

New product approvals are the key trends gaining popularity in the antibiotics market. Major companies in the market are receiving regulatory approvals for their novel antibiotic formulations. For instance, in January 2023, Alkem Laboratories Ltd., an Indian-based pharmaceutical company, launched Zidavi. The drug is a combination of ceftazidime and avibactam and is indicated for the treatment of complicated urinary tract infections, intra-abdominal infections, and pneumonia caused by multi-drug resistant (MDR) Gram-negative bacteria. Zidavi is a significant development in the fight against antibiotic resistance, as it is one of the few antibiotics that is effective against MDR Gram-negative bacteria.

Global Antibiotics Market Trend: Strategic Partnerships Drive Access To Essential Antibacterial Medications In The Antibiotic Market

Major companies operating in the antibiotics market are adopting a strategic partnership approach to provide access to novel antibacterial drugs. Strategic partnerships refer to a process in which companies leverage each other's strengths and resources to achieve mutual benefits and success. For instance, in June 2024, Orchid Pharma Limited, an India-based pharmaceutical company, announced a partnership with Cipla Limited, an India-based pharmaceutical company, to efficiently launch and distribute Cefepime-Enmetazobactam in India. This partnership combines Orchid Pharma's innovative drug development capabilities with Cipla's extensive distribution network to launch Cefepime-Enmetazobactam, an antibiotic approved for treating complicated urinary tract infections and pneumonia. The purpose is to enhance access to this critical medication across India while addressing the growing challenge of antimicrobial resistance (AMR) and promoting responsible antibiotic stewardship among healthcare providers.

Antibiotics Market Merger And Acquisition: Innoviva Enhances Antibiotics Portfolio With Acquisition Of Entasis Therapeutics Holdings Inc

In July 2022, Innoviva Inc., a US-based healthcare-specific asset management company, acquired Entasis Therapeutics Holdings Inc. for an undisclosed sum. This acquisition broadens, diversifies, and enriches Innoviva's portfolio by adding first-in-class antibiotics for multidrug-resistant Gram-negative bacteria and helps to expand its customer base. Entasis Therapeutics Holdings Inc. is a US-based late-stage clinical biopharmaceutical company dedicated to the development, production, and marketing of novel antibacterial products, that operates in the antibiotics market.

Regional Outlook For The Global Antibiotics Market

North America was the largest region in the antibiotics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antibiotics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the antibiotics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Antibiotics Market?

The antibiotics market consists of sales of Glycopeptides, Clindamycin, and Quinolones. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Antibiotics Industry?

The antibiotics market research report is one of a series of new reports from The Business Research Company that provides antibiotics market statistics, including the antibiotics industry global market size, regional shares, competitors with an antibiotics market share, detailed antibiotics market segments, market trends, and opportunities, and any further data you may need to thrive in the antibiotics industry. This antibiotics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Antibiotics Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 $89.31 billion
Revenue Forecast In 2034 $110.65 billion
Growth Rate CAGR of 5.5% from 2024 to 2033
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Drug Class: Penicillin, Cephalosporin, Aminoglycosides, Tetracycline, Macrolides, Fluoroquinolones, Sulfonamides, Other Classes
2) By Spectrum Of Activity: Broad-spectrum Antibiotic, Narrow-spectrum Antibiotic
3) By Route Of Administration: Oral, Intravenous, Other Routes
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
5) By Application: Skin Infections, Respiratory Infections, Urinary Tract Infections, Septicemia, Ear Infections, Gastrointestinal Infections, Other Applications Subsegments: 1) By Penicillin: Natural Penicillins, Aminopenicillins, Penicillinase-resistant Penicillins, Extended-spectrum Penicillins
2) By Cephalosporin: First-generation, Second-generation, Third-generation, Fourth-generation, Fifth-generation
3) By Aminoglycosides: Gentamicin, Tobramycin, Amikacin, Neomycin
4) By Tetracycline: Tetracycline, Doxycycline, Minocycline, Oxytetracycline
5) By Macrolides: Erythromycin, Azithromycin, Clarithromycin 6) By Fluoroquinolones: Ciprofloxacin, Levofloxacin, Moxifloxacin, Ofloxacin 7) By Sulfonamides: Sulfamethoxazole, Sulfadiazine, Sulfasalazine 8) By Other Classes: Glycopeptides, Lipopeptides, Streptogramins, Polymyxins
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi SA, Bristol Myers Squibb (BMS), AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc (GSK), Eli Lilly and Company, Gilead Sciences Inc., Boehringer Ingelheim, Viatris Inc, Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Daiichi Sankyo Company, Sun Pharmaceutical Industries Limited, Cipla Ltd., Ferring Pharmaceuticals, Hikma Pharmaceuticals plc, Lupin Pharmaceuticals Inc., Torrent Pharmaceuticals Ltd., Glenmark Pharmaceuticals Limited, Basilea Pharmaceutica Ltd., Paratek Pharmaceuticals Inc., Spero Therapeutics Inc., Nabriva Therapeutics Plc
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Antibiotics Market Characteristics

    3. Antibiotics Market Trends And Strategies

    4. Antibiotics Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

    5. Global Antibiotics Growth Analysis And Strategic Analysis Framework

    5.1. Global Antibiotics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    5.2. Analysis Of End Use Industries

    5.3. Global Antibiotics Market Growth Rate Analysis

    5.4. Global Antibiotics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

    5.5. Global Antibiotics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

    5.6. Global Antibiotics Total Addressable Market (TAM)

    6. Antibiotics Market Segmentation

    6.1. Global Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Penicillin

    Cephalosporin

    Aminoglycosides

    Tetracycline

    Macrolides

    Fluoroquinolones

    Sulfonamides

    Other Classes

    6.2. Global Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Broad-spectrum Antibiotic

    Narrow-spectrum Antibiotic

    6.3. Global Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Oral

    Intravenous

    Other Routes

    6.4. Global Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Hospital Pharmacy

    Retail Pharmacy

    Online Pharmacy

    6.5. Global Antibiotics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Skin Infections

    Respiratory Infections

    Urinary Tract Infections

    Septicemia

    Ear Infections

    Gastrointestinal Infections

    Other Applications

    6.6. Global Antibiotics Market, Sub-Segmentation Of Penicillin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Natural Penicillins

    Aminopenicillins

    Penicillinase-resistant Penicillins

    Extended-spectrum Penicillins

    6.7. Global Antibiotics Market, Sub-Segmentation Of Cephalosporin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    First-generation

    Second-generation

    Third-generation

    Fourth-generation

    Fifth-generation

    6.8. Global Antibiotics Market, Sub-Segmentation Of Aminoglycosides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Gentamicin

    Tobramycin

    Amikacin

    Neomycin

    6.9. Global Antibiotics Market, Sub-Segmentation Of Tetracycline, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Tetracycline

    Doxycycline

    Minocycline

    Oxytetracycline

    6.10. Global Antibiotics Market, Sub-Segmentation Of Macrolides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Erythromycin

    Azithromycin

    Clarithromycin

    6.11. Global Antibiotics Market, Sub-Segmentation Of Fluoroquinolones, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Ciprofloxacin

    Levofloxacin

    Moxifloxacin

    Ofloxacin

    6.12. Global Antibiotics Market, Sub-Segmentation Of Sulfonamides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Sulfamethoxazole

    Sulfadiazine

    Sulfasalazine

    6.13. Global Antibiotics Market, Sub-Segmentation Of Other Classes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Glycopeptides

    Lipopeptides

    Streptogramins

    Polymyxins

    7. Antibiotics Market Regional And Country Analysis

    7.1. Global Antibiotics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    7.2. Global Antibiotics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8. Asia-Pacific Antibiotics Market

    8.1. Asia-Pacific Antibiotics Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.3. Asia-Pacific Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.4. Asia-Pacific Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    9. China Antibiotics Market

    9.1. China Antibiotics Market Overview

    9.2. China Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.3. China Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.4. China Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    10. India Antibiotics Market

    10.1. India Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.2. India Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.3. India Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11. Japan Antibiotics Market

    11.1. Japan Antibiotics Market Overview

    11.2. Japan Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.3. Japan Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.4. Japan Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12. Australia Antibiotics Market

    12.1. Australia Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.2. Australia Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.3. Australia Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13. Indonesia Antibiotics Market

    13.1. Indonesia Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.2. Indonesia Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.3. Indonesia Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14. South Korea Antibiotics Market

    14.1. South Korea Antibiotics Market Overview

    14.2. South Korea Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.3. South Korea Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.4. South Korea Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15. Western Europe Antibiotics Market

    15.1. Western Europe Antibiotics Market Overview

    15.2. Western Europe Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.3. Western Europe Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.4. Western Europe Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16. UK Antibiotics Market

    16.1. UK Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.2. UK Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.3. UK Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17. Germany Antibiotics Market

    17.1. Germany Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.2. Germany Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.3. Germany Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18. France Antibiotics Market

    18.1. France Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.2. France Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.3. France Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19. Italy Antibiotics Market

    19.1. Italy Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.2. Italy Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.3. Italy Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20. Spain Antibiotics Market

    20.1. Spain Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.2. Spain Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.3. Spain Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21. Eastern Europe Antibiotics Market

    21.1. Eastern Europe Antibiotics Market Overview

    21.2. Eastern Europe Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.3. Eastern Europe Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.4. Eastern Europe Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22. Russia Antibiotics Market

    22.1. Russia Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.2. Russia Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.3. Russia Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23. North America Antibiotics Market

    23.1. North America Antibiotics Market Overview

    23.2. North America Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.3. North America Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.4. North America Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24. USA Antibiotics Market

    24.1. USA Antibiotics Market Overview

    24.2. USA Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.3. USA Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.4. USA Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25. Canada Antibiotics Market

    25.1. Canada Antibiotics Market Overview

    25.2. Canada Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.3. Canada Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.4. Canada Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26. South America Antibiotics Market

    26.1. South America Antibiotics Market Overview

    26.2. South America Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.3. South America Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.4. South America Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27. Brazil Antibiotics Market

    27.1. Brazil Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.2. Brazil Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.3. Brazil Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28. Middle East Antibiotics Market

    28.1. Middle East Antibiotics Market Overview

    28.2. Middle East Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.3. Middle East Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.4. Middle East Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29. Africa Antibiotics Market

    29.1. Africa Antibiotics Market Overview

    29.2. Africa Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.3. Africa Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.4. Africa Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    30. Antibiotics Market Competitive Landscape And Company Profiles

    30.1. Antibiotics Market Competitive Landscape

    30.2. Antibiotics Market Company Profiles

    30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis

    30.2.3. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis

    30.2.4. Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

    31. Antibiotics Market Other Major And Innovative Companies

    31.1. Bayer AG

    31.2. Novartis AG

    31.3. Sanofi SA

    31.4. Bristol Myers Squibb (BMS)

    31.5. AstraZeneca plc

    31.6. Abbott Laboratories

    31.7. GlaxoSmithKline plc (GSK)

    31.8. Eli Lilly and Company

    31.9. Gilead Sciences Inc.

    31.10. Boehringer Ingelheim

    31.11. Viatris Inc

    31.12. Teva Pharmaceutical Industries Ltd.

    31.13. Astellas Pharma Inc.

    31.14. Daiichi Sankyo Company

    31.15. Sun Pharmaceutical Industries Limited

    32. Global Antibiotics Market Competitive Benchmarking And Dashboard

    33. Key Mergers And Acquisitions In The Antibiotics Market

    34. Recent Developments In The Antibiotics Market

    35. Antibiotics Market High Potential Countries, Segments and Strategies

    35.1 Antibiotics Market In 2029 - Countries Offering Most New Opportunities

    35.2 Antibiotics Market In 2029 - Segments Offering Most New Opportunities

    35.3 Antibiotics Market In 2029 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Antibiotics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Antibiotics Market, Sub-Segmentation Of Penicillin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Antibiotics Market, Sub-Segmentation Of Cephalosporin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Antibiotics Market, Sub-Segmentation Of Aminoglycosides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Antibiotics Market, Sub-Segmentation Of Tetracycline, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Antibiotics Market, Sub-Segmentation Of Macrolides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Global Antibiotics Market, Sub-Segmentation Of Fluoroquinolones, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Global Antibiotics Market, Sub-Segmentation Of Sulfonamides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Global Antibiotics Market, Sub-Segmentation Of Other Classes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: Global Antibiotics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: Global Antibiotics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: Asia-Pacific, Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: Asia-Pacific, Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: Asia-Pacific, Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: China, Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: China, Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: China, Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: India, Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: India, Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: India, Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Japan, Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Japan, Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Japan, Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Australia, Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Australia, Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Australia, Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Indonesia, Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Indonesia, Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Indonesia, Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: South Korea, Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: South Korea, Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: South Korea, Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Western Europe, Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Western Europe, Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Western Europe, Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: UK, Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: UK, Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: UK, Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Germany, Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Germany, Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Germany, Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: France, Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: France, Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: France, Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Italy, Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Italy, Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Italy, Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Spain, Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Spain, Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Spain, Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Eastern Europe, Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: Eastern Europe, Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: Eastern Europe, Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: Russia, Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: Russia, Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: Russia, Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: North America, Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: North America, Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: North America, Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: USA, Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: USA, Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: USA, Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Canada, Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Canada, Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Canada, Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: South America, Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: South America, Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: South America, Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Brazil, Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Brazil, Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Brazil, Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Middle East, Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Middle East, Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 80: Middle East, Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 81: Africa, Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 82: Africa, Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 83: Africa, Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 84: Pfizer Inc. Financial Performance
  • Table 85: Johnson & Johnson Financial Performance
  • Table 86: F. Hoffmann-La Roche AG Financial Performance
  • Table 87: Merck & Co Inc. Financial Performance
  • Table 88: AbbVie Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Antibiotics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Antibiotics Market, Sub-Segmentation Of Penicillin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Antibiotics Market, Sub-Segmentation Of Cephalosporin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Antibiotics Market, Sub-Segmentation Of Aminoglycosides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Antibiotics Market, Sub-Segmentation Of Tetracycline, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Antibiotics Market, Sub-Segmentation Of Macrolides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Global Antibiotics Market, Sub-Segmentation Of Fluoroquinolones, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Global Antibiotics Market, Sub-Segmentation Of Sulfonamides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Global Antibiotics Market, Sub-Segmentation Of Other Classes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: Global Antibiotics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: Global Antibiotics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: Asia-Pacific, Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: Asia-Pacific, Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: Asia-Pacific, Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: China, Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: China, Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: China, Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: India, Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: India, Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: India, Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Japan, Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Japan, Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Japan, Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Australia, Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Australia, Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Australia, Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Indonesia, Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Indonesia, Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Indonesia, Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: South Korea, Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: South Korea, Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: South Korea, Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Western Europe, Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Western Europe, Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Western Europe, Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: UK, Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: UK, Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: UK, Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Germany, Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Germany, Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Germany, Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: France, Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: France, Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: France, Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Italy, Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Italy, Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Italy, Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Spain, Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Spain, Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Spain, Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Eastern Europe, Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: Eastern Europe, Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: Eastern Europe, Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: Russia, Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: Russia, Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: Russia, Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: North America, Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: North America, Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: North America, Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: USA, Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: USA, Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: USA, Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Canada, Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Canada, Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Canada, Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: South America, Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: South America, Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: South America, Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Brazil, Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Brazil, Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Brazil, Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Middle East, Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Middle East, Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 80: Middle East, Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 81: Africa, Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 82: Africa, Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 83: Africa, Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 84: Pfizer Inc. Financial Performance
  • Figure 85: Johnson & Johnson Financial Performance
  • Figure 86: F. Hoffmann-La Roche AG Financial Performance
  • Figure 87: Merck & Co Inc. Financial Performance
  • Figure 88: AbbVie Inc. Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report

Frequently Asked Questions

What is the definition of the Antibiotics market?

Antibiotics are a class of medications that work by either killing bacteria or inhibiting their growth, helping the body's immune system eliminate the infection. Antibiotics are used in the treatment of various infections caused by bacteria. For further insights on the Antibiotics market, request a sample here

How will the Antibiotics market drivers and restraints affect the market dynamics? What forces will shape the Antibiotics industry going forward?

The Antibiotics market major growth driver - Surge In Bacterial Prevalence Drives Growth In The Antibiotics Market. For further insights on the Antibiotics market, request a sample here

What is the forecast market size or the forecast market value of the Antibiotics market?

The Antibiotics market size has grown strongly in recent years. The antibiotics market size has grown strongly in recent years. It will grow from $84.68 billion in 2024 to $89.31 billion in 2025 at a compound annual growth rate (CAGR) of 5.5%. The growth in the historic period can be attributed to increased incidence of infectious diseases, growing population and urbanization, rising healthcare awareness, access to healthcare services, prevalence of antibiotic-resistant strains The antibiotics market size is expected to see strong growth in the next few years. It will grow to $110.65 billion in 2029 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to global health threats, rising healthcare expenditure, government initiatives and regulations, increased international collaboration. Major trends in the forecast period include development of oral antibiotics, collaboration and partnerships for antibiotic development, regulatory incentives and pathways, antimicrobial stewardship programs in healthcare, global health initiatives for antibiotic access. For further insights on the Antibiotics market, request a sample here

How is the Antibiotics market segmented?

The antibiotics market covered in this report is segmented –
1) By Drug Class: Penicillin, Cephalosporin, Aminoglycosides, Tetracycline, Macrolides, Fluoroquinolones, Sulfonamides, Other Classes
2) By Spectrum Of Activity: Broad-spectrum Antibiotic, Narrow-spectrum Antibiotic
3) By Route Of Administration: Oral, Intravenous, Other Routes
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
5) By Application: Skin Infections, Respiratory Infections, Urinary Tract Infections, Septicemia, Ear Infections, Gastrointestinal Infections, Other Applications Subsegments:
1) By Penicillin: Natural Penicillins, Aminopenicillins, Penicillinase-resistant Penicillins, Extended-spectrum Penicillins
2) By Cephalosporin: First-generation, Second-generation, Third-generation, Fourth-generation, Fifth-generation
3) By Aminoglycosides: Gentamicin, Tobramycin, Amikacin, Neomycin
4) By Tetracycline: Tetracycline, Doxycycline, Minocycline, Oxytetracycline
5) By Macrolides: Erythromycin, Azithromycin, Clarithromycin
6) By Fluoroquinolones: Ciprofloxacin, Levofloxacin, Moxifloxacin, Ofloxacin
7) By Sulfonamides: Sulfamethoxazole, Sulfadiazine, Sulfasalazine
8) By Other Classes: Glycopeptides, Lipopeptides, Streptogramins, Polymyxins For further insights on the Antibiotics market,
request a sample here

Which region has the largest share of the Antibiotics market? What are the other regions covered in the report?

North America was the largest region in the antibiotics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antibiotics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Antibiotics market, request a sample here.

Who are the major players in the Antibiotics market?

Major companies operating in the antibiotics market include Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi SA, Bristol Myers Squibb (BMS), AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc (GSK), Eli Lilly and Company, Gilead Sciences Inc., Boehringer Ingelheim, Viatris Inc, Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Daiichi Sankyo Company, Sun Pharmaceutical Industries Limited, Cipla Ltd., Ferring Pharmaceuticals, Hikma Pharmaceuticals plc, Lupin Pharmaceuticals Inc., Torrent Pharmaceuticals Ltd., Glenmark Pharmaceuticals Limited, Basilea Pharmaceutica Ltd., Paratek Pharmaceuticals Inc., Spero Therapeutics Inc., Nabriva Therapeutics Plc . For further insights on the Antibiotics market, request a sample here.

What are the key trends in the Antibiotics market?

Major trends in the Antibiotics market include Breaking Ground Against Antibiotic Resistance. For further insights on the Antibiotics market, request a sample here.

What are the major opportunities in the Antibiotics market? What are the strategies for the Antibiotics market?

For detailed insights on the major opportunities and strategies in the Antibiotics market, request a sample here.

How does the Antibiotics market relate to the overall economy and other similar markets?

For detailed insights on Antibiotics's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Antibiotics industry?

For detailed insights on the mergers and acquisitions in the Antibiotics industry, request a sample here.

What are the key dynamics influencing the Antibiotics market growth? SWOT analysis of the Antibiotics market.

For detailed insights on the key dynamics influencing the Antibiotics market growth and SWOT analysis of the Antibiotics industry, request a sample here.